Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) was the target of some unusual options trading activity on Thursday. Traders acquired 2,433 call options on the company. This represents an increase of approximately 1,997% compared to the average volume of 116 call options. Separately, HC Wainwright began coverage on shares of Praxis Precision Medicines in […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Rating) released its earnings results on Sunday. The company reported ($1.30) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.08) by ($0.22), MarketWatch Earnings reports. NASDAQ:PRAX opened at $13.08 on Wednesday. The company has a 50-day moving average of $15.57 and a 200-day moving average of […]